Business
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
BOCA RATON, Fla., May 07, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026.
About this update from Sensus Healthcare, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2404,"height":741,"url":"https://media.zenfs.com/en/business-wire.com/60bc5437ab9be971fa1893f709e70a23"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3G2ruKKcxwR7md6F8lLo_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI5Ng--/https://media.zenfs.com/en/business-wire.com/60bc5437ab9be971fa1893f709e70a23","width":960,"height":296},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/LflwIS6wSSRkDQFAudWsFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NDA-/https://media.zenfs.com/en/business-wire.com/60bc5437ab9be971fa1893f709e70a23","width":1200,"height":370}},"lazy":false},{"type":"text","content":"Dedicated CPT Codes for Superficial Radiotherapy (SRT) Now Effective, Driving Increased Customer Activity, Customer Diversification and Improved Physician Economics","length":164,"tagName":"p","attribs":{}},{"type":"text","content":"Sales Pipeline and Financing Activity Strengthen Following Reimbursement Clarity","length":80,"tagName":"p","attribs":{}},{"type":"text","content":"Expansion of Installed Base and Recurring Revenue Growth Driving Advancement Towards Profitability","length":98,"tagName":"p","attribs":{}},{"type":"text","content":"Exited the Quarter with $18.3 Million in Cash and No Debt","length":57,"tagName":"p","attribs":{}},{"type":"text","content":"BOCA RATON, Fla., May 07, 2026--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026.","length":332,"tagName":"p"},{"type":"text","content":"Highlights included:","length":20,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $3.4 million compared to $8.3 million for the three months ended March 31, 2025.","length":91,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Excluding sales to the Company’s historically largest customer, revenue increased from $2.7 million in the quarter ended March 31, 2025.","length":136,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":136,"olType":false}]},{"val":[{"type":"text","content":"Shippe...